Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations

Journal of Neurophysiology

Volumn 78, Issue 2, 1997, Pages 582-590

  Zhang, Li ^a   Peoples, Robert W ^a   Oz, Murat ^a   Harvey White, Judith ^a   Weight, Forrest F ^a   Brauneis, Ulrike ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; DYNORPHIN[1-13]; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; ION CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN FAMILY; SYNAPSE; XENOPUS;

EID: 0030805667     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1997.78.2.582     Document Type: Article

References (48)

1. BAKSHI, R. AND FADEN, A. I. Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects. Neurosci. Lett. 110: 113-117, 1990.
2. BODNER, G., PINTO, S., ALBECK, H., AND KREEK, M. J. Effects of dynorphin peptides on human natural killer cell activity in vitro. In: Problems of Drug Dependence, 1991: Proceedings of the 53rd Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc., edited by L. S. Harris. Palm Beach, FL: National Institute on Drug Abuse Research Monograph Series, 1992, vol. 119, p. 331.
3. BRAUNEIS, U., OZ, M., PEOPLES, R. W., WEIGHT, F. F., AND ZHANG, L. Inhibition of NMDA-activated current by dynorphin is subunit-specific and proceeds by a non-opioid mechanism. Soc. Neurosci. Abstr. 21: 834, 1995.
4. BRAUNEIS, U., OZ, M., PEOPLES, R. W., HARVEY-WHITE, J., WEIGHT, F. F., AND ZHANG, L. Potentiation of N-methyl-D-aspartate-receptor-mediated responses by dynorphin at low glycine. Soc. Neurosci. Abstr. 22: 67, 1996a.
5. BRAUNEIS, U., OZ, M., PEOPLES, R. W., WEIGHT, F. F., AND ZHANG, L. Differential sensitivity of recombinant N-methyl-D-aspartate receptor sub-units to inhibition by dynorphin. J. Pharmacol. Exp. Ther. 279: 1063-1068, 1996b.
6. 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J. Neurosci. 14: 5580-5589, 1994.
7. CAUDLE, R. M. AND ISAAC, L. A novel interaction between dynorphin (1-13) and an N-methyl-D-aspartate site. Brain Res. 443: 329-332, 1988.
8. CERNE, R., KOLAJ, M., AND RANDIC, M. Kappa opioid receptor activation depresses NMDA responses in acutely isolated neurons from the rat spinal dorsal horn. Soc. Neurosci. Abstr. 20: 481, 1994.
9. CHAVKIN, C., BAKHIT, C., WEBER, E., AND BLOOM, F. E. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc. Natl. Acad. Sci. USA 80: 7669-7673, 1983.
10. CHAVKIN, C., JAMES, I. F., AND GOLDSTEIN, A. Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science Wash. DC 215: 413-415, 1982.
11. CHEN, L., Gu, Y., AND HUANG, L.-Y.M. The opioid peptide dynorphin directly blocks NMDA-receptor channels in the rat. J. Physiol. Lond. 482: 575-581, 1995.
12. CHOU, J. Z., CHAIT, B. T., WANG, R., AND KREEK, M. J. Differential biotransformation of dynorphin A (1-17) and dynorphin A (1-13) peptides in human blood, ex vivo. Peptides 17: 983-990, 1996.
13. 2-17 inhibit adenylyl cyclase activity in rat caudate putamen. J. Pharmacol. Exp. Ther. 277: 359-365, 1996.
14. COHEN, S. A., BIDLINGMEYER, B. A., AND TARVIN, T. L. PITS derivatives in amino acid analysis. Nature Lond. 320: 769-770, 1986.
15. CRUZ, L. AND BASBAUM, A. I. Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat. J. Comp. Neurol. 240: 331-348, 1985.
16. DELEAN, A., MUNSON, P. J., AND RODBARD, D. Simultaneous analysis of families of sigmoidal curves: application of bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235 (Endocrinol. Metab. Gastrointest. Physiol. 4): E97-E102, 1978.
17. DUBNER, R. AND RUDA, M. A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15: 96-103, 1992.
18. DUMONT, M. AND LEMAIRE, S. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes. Eur. J. Pharmacol. 271: 241-244, 1994.
19. GOLDSTEIN. A., FISCHLI, W., LOWNEY, L. I., HUNKAPILLER, M., AND HOOD, L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 78: 7219-7223, 1979.
20. GOSLIN, K. AND BANKER, G. (Editors). Rat hippocampal neurons in ,low-density culture. In: Culturing Nerve Cells. Cambridge, MA: MIT Press, 1991, p. 251-281.
21. GUASTELLA, J., BRECHA, N., WEIGMANN, C., LESTER, H. A., AND DAVIDSON, N. Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc. Natl. Acad. Sci. USA 89: 7189-7193, 1992.
22. HENDERSON, G., JOHNSON, J. W., AND ASCHER, P. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J. Physiol. Lond. 430: 189-212, 1990.
23. HENRIKSEN, S. J., COUVET, G., AND BLOOM, F. E. In vivo cellular responses of electrophoretically applied dynorphin in the rat hippocampus. Life Sci. 31: 1785-1788, 1982.
24. HUTCHISON, W. D., MORTON, C. R., AND TERENIUS, L. Dynorphin A: in vivo release in the spinal cord of the rat. Brain Res. 532: 299-306, 1990.
25. IKEDA, K., NAGASAWA, M., MORI, H., ARAKI, K., SAKIMURA, K., WATANABE, M., INOUE, Y., AND MISHINA, M. Cloning and expression of the e4 subunit of the NMDA receptor channel. FEBS Lett. 313: 34-38, 1994.
26. JOHNSON, J. W. AND ASCHER, P. Equilibrium and kinetic study of glycine action on the W-methyl-D-aspartate receptor in cultured mouse brain neurons. J. Physiol. Lond. 455: 339-365, 1992.
27. JURSKY, F. AND NELSON, N. Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J. Neurochem. 64: 1026-1033, 1995.
28. KAKIDANI, H., FURUTANI, Y., TAKAHASHI, H., NODA, M., MORIMOTO, Y., HIROSE, T., ASAI, M., INAYAMA, S., NAKANISHI, S., AND NUMA, S. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/ dynorphin precursor. Nature Lond. 298: 245-249, 1982.
29. KLECKNER, N. W. AND DINGLEDINE, R. Requirements for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science Wash. DC 241: 835-837, 1988.
30. KUTSUWADA, T., KASHIWABUCHI, N., MORI, H., SAKIMURA, K., KUSHIYA, E., ARAKI, K., MEGURO, H., MASAKI, H., KUMANISHI, T., ARAKAWA, M., AND MISHINA, M. Molecular diversity of the NMDA receptor channel. Nature Lond. 357: 70-74, 1992.
31. MASSARDIER, D. AND HUNT, P. F. A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 170: 125-126, 1989.
32. MCGINTY, J., HENRIKSEN, S., GOLDSTEIN, A., TERENIUS, L., AND BLOOM, F. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration of colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 80: 589-593, 1983.
33. MCLEAN, S., ROTHMAN, R. B., JACOBSON, A. E., RICE, K. C., AND HERKENHAM, M. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J. Comp. Neurol. 255: 497-510, 1987.
34. MILLAN, M. H., MILLAN, M. J., AND HERZ, A. The hypothalamic paraventricular nucleus: relationship to brain and pituitary pools of vasopressin and oxytoxin as compared to dynorphin, β-endorphin and related opioid peptides in the rat. Neuroendocrinology 38: 108-116, 1984.
35. MOISES, H. C. AND WALKER, J. M. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat. Eur. J. Pharmacol. 108: 85-98, 1985.
36. MÜLLER, S. AND HOCHHAUS, G. Metabolism of dynorphin A (1-13) in human blood and plasma. Pharm. Res. 12: 1165-1170, 1995.
37. SEIZINGER, B. R., GRIMM, C., HOLLT, V., AND HERZ, A. Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of the rat brain and pituitary. J. Neurochem. 42: 447-457, 1984.
38. SHUKLA, V. K., BANSINATH, M., DUMONT, M., AND LEMAIRE, S. Selective involvement of kappa opioid and phenycyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro. Brain Res. 591: 176-180, 1992.
39. SKILLING, S. R., SUN, X., KURTZ, H. J., AND LARSON, A. A. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res. 575: 272-278, 1992.
40. SMITH, K. E., BORDEN, L. A., HARTIG, P. R., BRANCHEK, T., AND WEINSHANK, R. L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8: 927-935, 1992.
41. STEVENS, C. W., WEINGER, M. B., AND YAKSH, T. L. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats. Eur. J. Pharmacol. 138: 299-302, 1987.
42. 1] dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharmacol. Exp. Ther. 266: 121-124, 1993.
43. TERRIAN, D. M., DAMRON, D. S., DORMAN, R. V., AND GANNON, R. L. Effects of calcium antagonists on the evoked release of dynorphin A (1-8) and availability of intraterminal calcium in rat hippocampal mossy fiber synaptosomes. Neurosci. Lett. 106: 322-327, 1989.
44. 1-opioid receptors in guinea pig hippocampus. J. Neurochem. 57: 333-343, 1991.
45. WALKER, J. M., MOISES, H. C., COY, D. H., BALDRIGHI, G., AND AKIL, H. Nonopiate effects of dynorphin and des-tyr-dynorphin. Science Wash. DC 218: 1136-1138, 1982.
46. WATSON, S. J., AKIL, H., FISCHLI, W., GOLDSTEIN, A., ZIMMERMAN, E., NILAVER, G., AND VAN WIMERSMA GREIDANUS, T. B. Dynorphin and vasopressin common localization in magnocellular neurones. Science Wash. DC 218: 1185-1192, 1982.
47. WATSON, S. J., KHACHATURIAN, H., TAILOR, L., FISCHLI, W., GOLDSTEIN, A., AND AKIL, H. Pro-dynorphin peptides are found in the same neurons throughout the rat brain: immunocytochemical study. Proc. Natl. Acad. Sci. USA 80: 891-894, 1983.
48. WEISSKOPF, M., ZALUTSKY, R. A., AND NICOLL, R. A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature Lond. 362: 423-427, 1993.